Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 701

1.

Home-Based Family Intervention Increases Knowledge, Communication and Living Donation Rates: A Randomized Controlled Trial.

Ismail SY, Luchtenburg AE, Timman R, Zuidema WC, Boonstra C, Weimar W, Busschbach JJ, Massey EK.

Am J Transplant. 2014 Jun 16. doi: 10.1111/ajt.12751. [Epub ahead of print]

PMID:
24935081
[PubMed - as supplied by publisher]
2.

Understanding the Influence of Ethnicity and Socioeconomic Factors on Graft and Patient Survival After Kidney Transplantation.

Laging M, Kal-van Gestel JA, van de Wetering J, IJzermans JN, Weimar W, Roodnat JI.

Transplantation. 2014 Jun 12. [Epub ahead of print]

PMID:
24926831
[PubMed - as supplied by publisher]
3.

Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study.

Tielen M, van Exel J, Laging M, Beck DK, Khemai R, van Gelder T, Betjes MG, Weimar W, Massey EK.

J Transplant. 2014;2014:675301. doi: 10.1155/2014/675301. Epub 2014 Apr 28.

PMID:
24868449
[PubMed]
Free PMC Article
4.

The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients.

Bouvy AP, Klepper M, Kho MM, Boer K, Betjes MG, Weimar W, Baan CC.

Nephrol Dial Transplant. 2014 Apr 24. [Epub ahead of print]

PMID:
24771499
[PubMed - as supplied by publisher]
5.

Human Allogeneic Bone Marrow and Adipose Tissue Derived Mesenchymal Stromal Cells Induce CD8+ Cytotoxic T Cell Reactivity.

Roemeling-van Rhijn M, Reinders ME, Franquesa M, Engela AU, Korevaar SS, Roelofs H, Genever PG, Ijzermans JN, Betjes MG, Baan CC, Weimar W, Hoogduijn MJ.

J Stem Cell Res Ther. 2013 Dec 12;3(Suppl 6):004.

PMID:
24729944
[PubMed]
Free PMC Article
6.

Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells.

Demmers MW, Korevaar SS, Betjes MG, Weimar W, Rowshani AT, Baan CC.

Transplantation. 2014 Jun 15;97(11):1110-8. doi: 10.1097/TP.0000000000000108.

PMID:
24704664
[PubMed - in process]
7.

Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model.

Roemeling-van Rhijn M, Khairoun M, Korevaar SS, Lievers E, Leuning DG, Ijzermans JN, Betjes MG, Genever PG, van Kooten C, de Fijter HJ, Rabelink TJ, Baan CC, Weimar W, Roelofs H, Hoogduijn MJ, Reinders ME.

J Stem Cell Res Ther. 2013 Nov 25;Suppl 6(1):20780.

PMID:
24672744
[PubMed]
Free PMC Article
8.

The First Fifty ABO Blood Group Incompatible Kidney Transplantations: The Rotterdam Experience.

van Agteren M, Weimar W, de Weerd AE, Te Boekhorst PA, Ijzermans JN, van de Wetering J, Betjes MG.

J Transplant. 2014;2014:913902. doi: 10.1155/2014/913902. Epub 2014 Feb 6.

PMID:
24672705
[PubMed]
Free PMC Article
9.

The optimal MMF dose in tacrolimus treated patients.

van Gelder T, Bouamar R, Shuker N, Hesselink D, Weimar W, Kaplan B, Bernasconi C.

Am J Transplant. 2014 May;14(5):1221. doi: 10.1111/ajt.12682. Epub 2014 Mar 17. No abstract available.

PMID:
24636529
[PubMed - in process]
10.

Independent risk factors for urological complications after deceased donor kidney transplantation.

Slagt IK, Ijzermans JN, Visser LJ, Weimar W, Roodnat JI, Terkivatan T.

PLoS One. 2014 Mar 7;9(3):e91211. doi: 10.1371/journal.pone.0091211. eCollection 2014.

PMID:
24608797
[PubMed - in process]
Free PMC Article
11.

Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients.

Chen Z, Bouamar R, Van Schaik RH, De Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Weimar W, Hesselink DA, Van Gelder T.

Clin Transplant. 2014 Jun;28(6):649-55. doi: 10.1111/ctr.12346. Epub 2014 Jun 3.

PMID:
24579958
[PubMed - in process]
12.

15-Year Follow-up of a Multicenter, Randomized, Calcineurin Inhibitor Withdrawal Study in Kidney Transplantation.

Roodnat JI, Hilbrands LB, Hené RJ, de Sévaux RG, Smak Gregoor PJ, Kal-van Gestel JA, Konijn C, van Zuilen A, van Gelder T, Hoitsma AJ, Weimar W.

Transplantation. 2014 Jul 15;98(1):47-53. doi: 10.1097/01.TP.0000442774.46133.71.

PMID:
24521775
[PubMed - in process]
13.

Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis.

de Weerd A, Vonk A, van der Hoek H, van Groningen M, Weimar W, Betjes M, van Agteren M.

BMC Nephrol. 2014 Feb 12;15(1):31. doi: 10.1186/1471-2369-15-31.

PMID:
24517251
[PubMed - in process]
Free PMC Article
14.

Coordinating unspecified living kidney donation and transplantation across the blood-type barrier in kidney exchange.

Glorie KM, de Klerk M, Wagelmans AP, van de Klundert JJ, Zuidema WC, Claas FH, Weimar W.

Transplantation. 2013 Nov 15;96(9):814-20.

PMID:
24350335
[PubMed - indexed for MEDLINE]
15.

Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation.

Betjes MG, Weimar W, Litjens NH.

J Transplant. 2013;2013:841430. doi: 10.1155/2013/841430. Epub 2013 Oct 1.

PMID:
24288592
[PubMed]
Free PMC Article
16.

A randomized controlled trial comparing intravesical to extravesical ureteroneocystostomy in living donor kidney transplantation recipients.

Slagt IK, Dor FJ, Tran TC, Kimenai HJ, Weimar W, Ijzermans JN, Terkivatan T.

Kidney Int. 2014 Feb;85(2):471-7. doi: 10.1038/ki.2013.464. Epub 2013 Nov 27.

PMID:
24284515
[PubMed - in process]
17.

Can right-sided hand-assisted retroperitoneoscopic donor nephrectomy be advocated above standard laparoscopic donor nephrectomy: a randomized pilot study.

Klop KW, Kok NF, Dols LF, Dor FJ, Tran KT, Terkivatan T, Weimar W, Ijzermans JN.

Transpl Int. 2014 Feb;27(2):162-9. doi: 10.1111/tri.12226. Epub 2013 Nov 25.

PMID:
24268098
[PubMed - in process]
18.

Survival prognosis after the start of a renal replacement therapy in the Netherlands: a retrospective cohort study.

Hemke AC, Heemskerk MB, van Diepen M, Weimar W, Dekker FW, Hoitsma AJ.

BMC Nephrol. 2013 Nov 20;14:258. doi: 10.1186/1471-2369-14-258.

PMID:
24256551
[PubMed - indexed for MEDLINE]
Free Article
19.

Ischemic postconditioning in human DCD kidney transplantation is feasible and appears safe.

van den Akker EK, Hesselink DA, Manintveld OC, Lafranca JA, de Bruin RW, Weimar W, Ijzermans JN, Dor FJ.

Transpl Int. 2014 Feb;27(2):226-34. doi: 10.1111/tri.12242. Epub 2013 Dec 11.

PMID:
24236960
[PubMed - in process]
20.

Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.

Laging M, Kal-van Gestel JA, Haasnoot GW, Claas FH, van de Wetering J, Ijzermans JN, Weimar W, Roodnat JI.

Transplantation. 2014 Feb 15;97(3):330-6. doi: 10.1097/01.TP.0000435703.61642.43.

PMID:
24202143
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk